Friday, August 7, 2026

Pharmaresearch Acquires CG USA to Strengthen Localization Strategy for Rejuran Cosmetics in the U.S.

Pharmaresearch acquires CG USA to enhance supply chain and meet growing demand for Rejuran Cosmetics in North America.

JLK Secures FDA Clearance for Stroke Analysis Solution… Advancing Clinical Workflow

JLK's "JLK-NCCT" receives FDA clearance for AI-based stroke analysis, enhancing early detection and triage in emergency settings.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

Jin Joong Hwang

Author's Latest

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Unlock Better Sleep: Daewon Health’s New Honey Sleep Shot Hits Olive Young!

Daewon Pharmaceutical launches Good Night Shot, a sleep aid featuring lime peel extract, at Olive Young's seasonal sale for millennials and Gen Z.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Discover the Future of Aesthetic Treatments: How Nanotechnology is Transforming the Beauty Industry

DongKoo Bio&Pharma partners with Supernova Bio and Areum Medics to innovate aesthetic treatments using advanced nanoparticle technology.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Discover the Future of Aesthetic Medicine: URO-UEMXD and Derma Shine Duo RF Unveiled at WHX Dubai 2026

Huons Meditech showcased innovative medical devices at WHX Dubai 2026, highlighting advancements in urology and aesthetics.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.